Cellular resistance to bleomycin in Saccharomyces cerevisiae is not affected by changes in bleomycin hydrolase levels

Biochemistry and Cell Biology

Volumn 80, Issue 6, 2002, Pages 789-796

  Wang, Huijie ^a   Ramotar, Dindial ^a  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

Bleomycin; Bleomycin hydrolase; DNA damage; Resistance; Yeast

Indexed keywords

DRUG THERAPY; ENZYMES; MUTAGENESIS; TUMORS; YEAST;

LETHAL EFFECTS;

BIOCHEMISTRY;

BLEOMYCIN; BLEOMYCIN HYDROLASE; PROTEINASE; CYSTEINE PROTEINASE; IMP2 PROTEIN, S CEREVISIAE; NUCLEAR PROTEIN; SACCHAROMYCES CEREVISIAE PROTEIN; TRANSACTIVATOR PROTEIN;

ARTICLE; CELLULAR RESISTANCE; CONTROLLED STUDY; DNA DAMAGE; DRUG DEGRADATION; DRUG EFFECT; DRUG SENSITIVITY; FUNGAL STRAIN; GENE DELETION; GENOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LETHALITY; MUTANT; NONHUMAN; PROTEIN EXPRESSION; SACCHAROMYCES CEREVISIAE; TUMOR RESISTANCE; YEAST; YEAST CELL; ANTIBIOTIC RESISTANCE; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOCHEMISTRY; METABOLISM; MUTATION; WESTERN BLOTTING;

SACCHAROMYCES; SACCHAROMYCES CEREVISIAE;

BLEOMYCIN; BLOTTING, WESTERN; CYSTEINE ENDOPEPTIDASES; DRUG RESISTANCE, FUNGAL; GENE EXPRESSION REGULATION, FUNGAL; IMMUNOCHEMISTRY; MUTATION; NUCLEAR PROTEINS; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; TRANS-ACTIVATORS;

EID: 0038437875     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/o02-167     Document Type: Article

References (55)

1. Akiyama, S., Ikezaki, K., Kuramochi, H., Takahashi, K., and Kuwano, M. 1981. Bleomycin-resistant cells contain increased bleomycin-hydrolase activities. Biochem. Biophys. Res.
2. Bennett, R.A., Swerdlow, P.S., and Povirk, L.F. 1993. Spontaneous cleavage of bleomycin-induced abasic sites in chromatin and their mutagenicity in mammalian shuttle vectors. Biochemistry, 32: 3188-3195.
3. Bromme, D., Rossi, A.B., Smeekens, S.P., Anderson, D.C., and Payan, D.G. 1996. Human bleomycin hydrolase: molecular cloning, sequencing, functional expression, and enzymatic characterization. Biochemistry, 35: 6706-6714.
4. Burger, R.M. 1998. Cleavage of nucleic acids by bleomycin. Chem. Rev. 98: 1153-1169.
5. Burger, R.M., Peisach, J., Blumberg, W.E., and Horwitz, S.B. 1979. Iron-bleomycin interactions with oxygen and oxygen analogues. Effects on spectra and drug activity. J. Biol. Chem. 254: 10 906-10 912.
6. Burger, R.M., Berkowitz, A.R., Peisach, J., and Horwitz, S.B. 1980. Origin of malondialdehyde from DNA degraded by Fe(II) x bleomycin. J. Biol. Chem. 255: 11 832 - 11 838.
7. Burger, R.M., Peisach, J., and Horwitz, S.B. 1981a. Activated bleomycin. A transient complex of drug, iron, and oxygen that degrades DNA. J. Biol. Chem. 256: 11 636 - 11 644.
8. Burger, R.M., Peisach, J., and Horwitz, S.B. 1981b. Mechanism of bleomycin action: in vitro studies. Life Sci. 28: 715-727.
9. Dar, M.E., and Jorgensen, T.J. 1995. Deletions at short direct repeats and base substitutions are characteristic mutations for bleomycin-induced double-and single-strand breaks, respectively, in a human shuttle vector system. Nucleic Acids Res. 23: 3224-3230.
10. Don, R.H., Cox, P.T., Wainwright, B.J., Baker, K., and Mattick, J.S. 1991. 'Touchdown' PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res. 19: 4008.
11. Ekimoto, H., Kuramochi, H., Takahashi, K., Matsuda, A., and Umezawa, H. 1980. Kinetics of the reaction of bleomycin-Fe(II)-O2 complex with DNA. J. Antibiot. (Tokyo), 33: 426-434.
12. Enenkel, C., and Wolf, D.H. 1993. BLH1 codes for a yeast thiol aminopeptidase, the equivalent of mammalian bleomycin hydrolase. J. Biol. Chem. 268: 7036-7043.
13. Gershoni, J.M., and Palade, G.E. 1983. Protein blotting: principles and applications. Anal. Biochem. 131: 1-15.
14. Gietz, D., St. Jean, A., Woods, R.A., and Schiestl, R.H. 1992. Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Res. 20: 1425.
15. Goldstein, A.L., McCusker, J.H., Knop, M., Siegers, K., Pereira, G., Zachariae, W., Winsor, B., Nasmyth, K., Schiebel, E., Pan, X., Wach, A., Brachat, A., Pohlmann, R., and Philippsen, P. 1999. Three new dominant drug resistance cassettes for gene disruption in Saccharomyces cerevisiae. Epitope tagging of yeast genes using a PCR-based strategy: more tags and improved practical routines. Heterologous URA3MX cassettes for gene replacement in Saccharomyces cerevisiae. New heterologous modules for classical or PCR-based gene disruptions in Saccharomyces cerevisiae. Yeast, 15: 1541-1553.
16. Guthrie, C., and Fink, G.R. 1991. Guide to yeast genetics and molecular biology. Meth. Enzymol. 194: 3-37.
17. Jani, J.P., Mistry, J.S., Morris, G., Davies, P., Lazo, J.S., and Sebti, S.M. 1992. In vivo circumvention of human colon carcinoma resistance to bleomycin. Cancer Res. 52: 2931-2937.
18. Joshua-Tor, L., Xu, H.E., Johnston, S.A., and Rees, D.C. 1995. Crystal structure of a conserved protease that binds DNA: the bleomycin hydrolase, Ga16. Science, 269: 945-950.
19. Kambouris, N.G., Burke, D.J., and Creutz, C.E. 1992. Cloning and characterization of a cysteine proteinase from Saccharomyces cerevisiae. J. Biol. Chem. 267: 21 570 - 21 576.
20. Koldamova, R.P., Lefterov, I.M., DiSabella, M.T., and Lazo, J.S. 1998. An evolutionarily conserved cysteine protease, human bleomycin hydrolase, binds to the human homologue of ubiquitin-conjugating enzyme 9. Mol. Pharmacol. 54: 954-961.
21. Koldamova, R.P., Lefterov, I.M., DiSabella, M.T., Almonte, C., Watkins, S.C., and Lazo, J.S. 1999. Human bleomycin hydrolase binds ribosomal proteins. Biochemistry, 38: 7111-7117.
22. Lazo, J.S., and Humphreys, C.J. 1983. Lack of metabolism as the biochemical basis of bleomycin-induced pulmonary toxicity. Proc. Natl. Acad. Sci. U.S.A. 80: 3064-3068.
23. Lazo, J.S., Sebti, S.M., and Schellens, J.H. 1996. Bleomycin. Cancer Chemother. Biol. Response Modif. 16: 39-47.
24. Lefterov, I.M., Koldamova, R.P., Lefterova, M.I., Schwartz, D.R., and Lazo, J.S. 2001. Cysteine 73 in bleomycin hydrolase is critical for amyloid precursor protein processing. Biochem. Biophys. Res. Commun. 283: 994-999.
25. Magdolen, U., Muller, G., Magdolen, V., and Bandlow, W. 1993. A yeast gene (BLH1) encodes a polypeptide with high homology to vertebrate bleomycin hydrolase, a family member of thiol proteinases. Biochim. Biophys. Acta, 1171: 299-303.
26. Masson, J.Y., and Ramotar, D. 1996. The Saccharomyces cerevisiae IMP2 gene encodes a transcriptional activator that mediates protection against DNA damage caused by bleomycin and other oxidants. Mol. Cell Biol. 16: 2091-2100.
27. Miyaki, M., Ono, T., Hori, S., and Umezawa, H. 1975. Binding of bleomycin to DNA in bleomycin-sensitive and -resistant rat ascites hepatoma cells. Cancer Res. 35: 2015-2019.
28. Morris, G., Mistry, J.S., Jani, J.P., Mignano, J.E., Sebti, S.M., and Lazo, J.S. 1992. Neutralization of bleomycin hydrolase by an epitope-specific antibody. Mol. Pharmacol. 42: 57-62.
29. Nishimura, C., Suzuki, H., Tanaka, N., and Yamaguchi, H. 1989. Bleomycin hydrolase is a unique thiol aminopeptidase. Biochem. Biophys. Res. Commun. 163: 788-796.
30. O'Farrell, P.A., Gonzalez, F., Zheng, W., Johnston, S.A., and Joshua-Tor, L. 1999. Crystal structure of human bleomycin hydrolase, a self- compartmentalizing cysteine protease. Structure Fold Des. 7: 619-627.
31. Oluwatosin, Y.E., and Kane, P.M. 1998. Mutations in the yeast KEX2 gene cause a Vma(-)-like phenotype: a possible role for the Kex2 endoprotease in vacuolar acidification. Mol. Cell Biol. 18: 1534-1543.
32. Pavon, V., Esteve, I., Guerrero, R., Villaverde, A., and Gaju, N. 1995. Induced mutagenesis by bleomycin in the purple sulfur bacterium Thiocapsa roseopersicina. Curr. Microbiol. 30: 117-120.
33. Pei, Z., Calmels, T.P., Creutz, C.E., and Sebti, S.M. 1995. Yeast cysteine proteinase gene ycp1 induces resistance to bleomycin in mammalian cells. Mol. Pharmacol. 48: 676-681.
34. Povirk, L.F., and Austin, M.J. 1991. Genotoxicity of bleomycin. Mutat. Res. 257: 127-143.
35. Povirk, L.F., Wubter, W., Kohnlein, W., and Hutchinson, F. 1977. DNA double-strand breaks and alkali-labile bonds produced by bleomycin. Nucleic Acids Res. 4: 3573-3580.
36. Ramotar, D., and Masson, J.Y. 1996. A Saccharomyces cerevisiae mutant defines a new locus essential for resistance to the antitumour drug bleomycin. Can. J. Microbiol. 42: 835-843.
37. Ramotar, D., Kim, C., Lillis, R., and Demple, B. 1993. Intracellular localization of the Apn1 DNA repair enzyme of Saccharomyces cerevisiae. Nuclear transport signals and biological role. J. Biol. Chem. 268: 20 533 - 20 539.
38. Sambrook, J., Fritsch, E.F., and Maniatis, T. 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Woodbury, N. Y.
39. Sanger, F., Nicklen, S., and Coulson, A.R. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. U.S.A. 74: 5463-5467.
40. Schwartz, D.R., Homanics, G.E., Hoyt, D.G., Klein, E., Abernethy, J., and Lazo, J.S. 1999. The neutral cysteine protease bleomycin hydrolase is essential for epidermal integrity and bleomycin resistance. Proc. Natl. Acad. Sci. U.S.A. 96: 4680-4685.
41. Sebti, S.M., and Lazo, J.S. 1988. Metabolic inactivation of bleomycin analogs by bleomycin hydrolase. Pharmacol. Ther. 38: 321-329.
42. Sebti, S.M., Jani, J.P., Mistry, J.S., Gorelik, E., and Lazo, J.S. 1991. Metabolic inactivation: a mechanism of human tumor resistance to bleomycin. Cancer Res. 51: 227-232.
43. Sherman, F., Fink, G., and Hicks, J. 1983. Methods in yeast genetics, Cold Spring Harbor Laboratory Press, Woodbury, N. Y.
44. Steighner, R.J., and Povirk, L.F. 1990. Effect of in vitro cleavage of apurinic/apyrimidinic sites on bleomycin-induced mutagenesis of repackaged lambda phage. Mutat. Res. 240: 93-100.
45. Tates, A.D., van Dam, F.J., Natarajan, A.T., Zwinderman, A.H., and Osanto, S. 1994. Frequencies of HPRT mutants and micronuclei in lymphocytes of cancer patients under chemotherapy: a prospective study. Mutat. Res. 307: 293-306.
46. Umezawa, H. 1965. Bleomycin and other antitumor antibiotics of high molecular weight. Antimicrobial Agents Chemother. 5: 1079-1085.
47. Umezawa, H. 1971. Natural and artificial bleomycins: chemistry and antitumor activities. Pure Appl. Chem. 28: 665-680.
48. Umezawa, H., Maeda, K., Takeuchi, T., and Okami, Y. 1966. New antibiotics, bleomycin A and B. J. Antibiot. (Tokyo), 19: 200-209.
49. Umezawa, H., Hori, S., Sawa, T., Yoshioka, T., and Takeuchi, T. 1974. A bleomycin-inactivating enzyme in mouse liver. J. Antibiot. (Tokyo), 27: 419-424.
50. Urade, M., Ogura, T., Mima, T., and Matsuya, T. 1992. Establishment of human squamous carcinoma cell lines highly and minimally sensitive to bleomycin and analysis of factors involved in the sensitivity. Cancer, 69: 2589-2597.
51. Wharam, M.D., Phillips, T.L., Kane, L., and Utley, J.F. 1973. Response of a murine solid tumor to in vivo combined chemotherapy and irradiation. Radiology, 109: 451-455.
52. Worth, L., Jr., Frank, B.L., Christner, D.F., Absalon, M.J., Stubbe, J., and Kozarich, J.W. 1993. Isotope effects on the cleavage of DNA by bleomycin: mechanism and modulation. Biochemistry, 32: 2601-2609.
53. Xu, H.E., and Johnston, S.A. 1994. Yeast bleomycin hydrolase is a DNA-binding cysteine protease. Identification, purification, biochemical characterization. J. Biol. Chem. 269: 21 177 - 21 183.
54. Zheng, W., Xu, H.E., and Johnston, S.A. 1997. The cysteine-peptidase bleomycin hydrolase is a member of the galactose regulon in yeast. J. Biol. Chem. 272: 30 350 - 30 355.
55. Zheng, W., Johnston, S.A., and Joshua-Tor, L. 1998. The unusual active site of Ga16/bleomycin hydrolase can act as a carboxypeptidase, aminopeptidase, and peptide ligase. Cell, 93: 103-109.